Telo Genomics Corp V.TELO

Alternate Symbol(s): TDSGF

Telo Genomics Corp. is a Canada-based biotech company. The Company is focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions. The Company, through its wholly owned subsidiary, Telo Genomics Holdings Corp., is developing diagnostic and prognostic products for diseases that display genomic instability. Its lead product, TeloView SMM, is a high-complexity molecular assay available for clinical use to provide information to physicians treating patients with Smoldering Multiple Myeloma. Through proprietary telomere-based analysis, TeloView SMM selects high-risk SMM patients who are likely to benefit from earlier treatment intervention while identifying the larger subset of low-risk SMM patients who have a more stable form of the disease and do not require immediate treatment. The TeloView SMM assay has a potential total addressable market of over 500,000 tests per year.

TSXV:TELO - Post by User

Telo Genomics Corp

Bullboard Posts

Comment by jammingthepipelineon Dec 12, 2017 4:34pm

153 Views

Post# 27141755

RE:Tailwinds Reasearch, promo

It looks like there is some accumulation going on together with tax loss selling. If the tax loss selling stops just before Christmas, probably we will see some upwards pressure in the SP.

2017 was an ugly year for DXD. Let's hpe that 2018 will be the year of truth.

It would be nice to get a NR with some explanation what is planned in the coming weeks and months. But that is wishful thinking from my part.

Bullboard Posts

Increasing summer travel could see these airline stocks soar